Top insider buys: Dec 13 – Dec 19, 2021

The largest open-market purchases company insiders reported on SEC Form 4 between Dec 13 – Dec 19, 2021.

Week 50, 2021

#CompanyWho boughtSharesValueSource
1GIC

GLOBAL INDUSTRIAL Co

3 officers/directors

Cluster buy

Robert Leeds, Bruce Leeds, Richard Leeds

5,687,726

$184.1M

SEC filings
2ET

Energy Transfer LP

4 officers/directors

Cluster buy

Matthew S. Ramsey, Thomas E. Long, Bradford D. Whitehurst, Kelcy L. Warren

16,290,367

$121.4M

SEC filings
3KPLT

Katapult Holdings, Inc.

3 officers/directors

Cluster buy

Curo Financial Technologies Corp., Donald Gayhardt, Christopher A. Masto

7,945,500

$29.7M

SEC filings
4VERO

Venus Concept Inc.

3 officers/directors

Cluster buy

EW Healthcare Partners, L.P., Richard Scott Barry, HealthQuest Partners II, L.P., Keith J. Sullivan, Garheng Kong

5,600,000

$7.0M

+$6.9M by large holders

SEC filings
5UEPS

NET 1 UEPS TECHNOLOGIES INC

3 officers/directors

Cluster buy

Antony C. Ball, Monde Nkosi, Lincoln Camagu Mali

405,216

$1.8M

SEC filings
6JXN

Jackson Financial Inc.

2 officers/directors

Cluster buy

Derek G. Kirkland, Paul Chadwick Myers

45,425

$1.5M

SEC filings
7RWAY

Runway Growth Finance Corp.

3 officers/directors

Cluster buy

OCM Growth Holdings LLC, Thomas B. Raterman, R. David Spreng

105,711

$1.4M

SEC filings
8AMRX

Amneal Pharmaceuticals, Inc.

2 officers/directors

Cluster buy

Chirag K. Patel, Chintu Patel

300,000

$1.3M

SEC filings
9PSN

PARSONS CORP

2 officers/directors

Cluster buy

George L. Ball, Michael Richard Kolloway

36,000

$1.1M

SEC filings
10AGLE

Aeglea BioTherapeutics, Inc.

3 officers/directors

Cluster buy

Armen Shanafelt, Anthony G. Quinn, Jonathan Alspaugh

253,634

$935K

SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.